Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 20/20 | 0.49 |
| ▸ | TDO2 | P48775 | 5/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.45 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22274721 | 0.94 | IDO1 (0.48) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL21187176 | 0.85 | IDO1 (0.60) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL20935477 | 0.81 | IDO1 (0.54) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL22812954 | 0.81 | IDO1 (0.54) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL22230784 | 0.80 | IDO1 (0.50) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL22259470 | 0.80 | IDO1 (0.50) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL20935478 | 0.80 | IDO1 (0.56) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL21384588 | 0.80 | IDO1 (0.48) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL20935295 | 0.79 | IDO1 (0.63) | IDO1TDO2CYP2C9CYP2C8CHRNA1 | |
| SCHEMBL20935286 | 0.79 | IDO1 (0.51) | IDO1TDO2CYP2C9CYP2C8CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019078968-A2 | CYCLIC COMPOUNDS AS IMMUNOMODULATING AGENTS | ANGEX PHARMACEUTICAL, INC. (US) | 2019-04-25 | — | — | WO | disclosed |